Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

167440

registered interest
date	02/12/2014
answering body	Ministry of Defence
answering dept id	11
answering dept short name	Defence
answering dept sort name	Defence
hansard heading	NATO Response Force
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Defence, pursuant to the written Answer of 17 November 2014 to Question 213740, whether the NATO MQ9 Users Group will be available for use as part of the NATO rapid reaction force.
tabling member constituency	West Bromwich East
tabling member printed	Mr Tom Watson
uin	216827
answer	answer is ministerial correction date of answer 05/12/2014 answer text <p>The NATO MQ-9 Users Group will promote cooperation, commonality, cost efficiency, and interoperability between members but will not generate operational capability. The first meetings are due to be held in Paris during January 2015.</p><p> </p> answering member constituency Rayleigh and Wickford answering member printed Mr Mark Francois question first answered 05/12/2014 13:39:46 answering member 1444 label Biography information for Mr Mark Francois
tabling member	1463 label Biography information for Lord Watson of Wyre Forest

167442

registered interest
date	02/12/2014
answering body	Ministry of Defence
answering dept id	11
answering dept short name	Defence
answering dept sort name	Defence
hansard heading	Middle East
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Defence, whether any personnel from Reaper Squadron 39 have been deployed to (a) Al Udeid air base, Qatar, (b) Al Minhad airbase, United Arab Emirates and (c) Al Musannah airbase, Oman.
tabling member constituency	West Bromwich East
tabling member printed	Mr Tom Watson
uin	216796
answer	answer is ministerial correction date of answer 05/12/2014 answer text <p>I am withholding this information as its disclosure would or would be likely to prejudice operational capability, effectiveness or security; also relations between the United Kingdom and other states.</p><p> </p><p> </p> answering member constituency Rayleigh and Wickford answering member printed Mr Mark Francois question first answered 05/12/2014 13:38:39 answering member 1444 label Biography information for Mr Mark Francois
tabling member	1463 label Biography information for Lord Watson of Wyre Forest

167443

registered interest
date	02/12/2014
answering body	Ministry of Defence
answering dept id	11
answering dept short name	Defence
answering dept sort name	Defence
hansard heading	Syria
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Defence, with reference to the Written Statement of 21 October 2014, Official Report, column 63WS, whether laser designators on UK Reapers carrying out surveillance missions in Syria are marking targets.
tabling member constituency	West Bromwich East
tabling member printed	Mr Tom Watson
uin	216785
answer	answer is ministerial correction date of answer 05/12/2014 answer text <p>Laser designators on UK Reapers have not been used to mark targets in Syria.</p> answering member constituency Rayleigh and Wickford answering member printed Mr Mark Francois question first answered 05/12/2014 13:39:11 answering member 1444 label Biography information for Mr Mark Francois
tabling member	1463 label Biography information for Lord Watson of Wyre Forest

157017

registered interest
date	20/11/2014
answering body	Ministry of Justice
answering dept id	54
answering dept short name	Justice
answering dept sort name	Justice
hansard heading	Child Abuse in North Wales Judicial Inquiry Review
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Justice, whether he plans to publish the Macur Report before May 2015.
tabling member constituency	West Bromwich East
tabling member printed	Mr Tom Watson
uin	215377
answer	answer is ministerial correction date of answer 25/11/2014 answer text <p>I answered a similar question on 20 November from the hon. Member for Wrexham and the position has not changed.</p><p> </p><p>Lady Justice Macur’s Review is entirely independent of Government and its timetable is a matter for her. She is on record as saying that her Review would be thorough and that she would not draw any conclusions until she had considered all the evidence. I am, however, confident that good progress has been made and the Review is nearing its completion. The Government looks forward to receiving Lady Justice Macur’s Report next year.</p> answering member constituency Bermondsey and Old Southwark answering member printed Simon Hughes question first answered 25/11/2014 12:59:49 answering member 194 label Biography information for Simon Hughes
tabling member	1463 label Biography information for Lord Watson of Wyre Forest

156795

registered interest
date	19/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Chemicals: Safety
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if he will review the safety of the anti-bacterial agent Tricolsan; if he will place in the Library copies of reports his Department has received on the safety of this chemical in the last 12 months; and if he will make a statement.
tabling member constituency	West Bromwich East
tabling member printed	Mr Tom Watson
uin	215165
answer	answer is ministerial correction date of answer 24/11/2014 answer text <p>Triclosan is an antimicrobial agent that is present as an active ingredient in some pharmaceutical products, such as antiseptic skin solutions and medicinal toothpastes. As with all medicinal products, the Medicines and Healthcare products Regulatory Agency (MHRA) keeps the safety of triclosan-containing pharmaceuticals under continual review. The view of the MHRA is that the balance of risks and benefits of such products continues to be favourable. The MHRA is unaware of any new data relevant to humans to alter this view.</p><p> </p><p> </p><p> </p><p>Triclosan has also been used for more than 35 years in a wide range of consumer products for its antiseptic, disinfectant and preservative properties. This includes some soaps, cosmetics, detergents, shampoos, toothpastes and mouth washes.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 24/11/2014 17:38:14 answering member 4020 label Biography information for George Freeman
tabling member	1463 label Biography information for Lord Watson of Wyre Forest

147474

registered interest
date	10/11/2014
answering body	Ministry of Defence
answering dept id	11
answering dept short name	Defence
answering dept sort name	Defence
hansard heading	Weapons
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Defence, if his Department will undertake reviews under Article 36 of Additional Protocol 1 to the 1949 Geneva Conventions before developing weapons systems capable of generating attack profiles.
tabling member constituency	West Bromwich East
tabling member printed	Mr Tom Watson
uin	214078
answer	answer is ministerial correction date of answer 20/11/2014 answer text <p>Yes, the Ministry of Defence does undertake reviews under Article 36 of Additional Protocol 1 to the 1949 Geneva Conventions. All new weapon systems, and any significant upgrades to existing system, are subject to a robust legal review.</p> answering member constituency Rayleigh and Wickford answering member printed Mr Mark Francois question first answered 20/11/2014 16:58:21 answering member 1444 label Biography information for Mr Mark Francois
tabling member	1463 label Biography information for Lord Watson of Wyre Forest

147475

registered interest
date	10/11/2014
answering body	Ministry of Defence
answering dept id	11
answering dept short name	Defence
answering dept sort name	Defence
hansard heading	Afghanistan
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Defence, with reference to the Answer of 20 March 2014 to Question 191671, and the recommendations of the Birmingham Policy Commission entitled The Security Impact of Drones, published on 22 October 2014, if his Department will request that ISAF publish, with any necessary redactions, the investigations report into the incident on 25 March 2011 in Afghanistan.
tabling member constituency	West Bromwich East
tabling member printed	Mr Tom Watson
uin	214077
answer	answer is ministerial correction date of answer 17/11/2014 answer text <p>The Department has no plans to make a request to ISAF to publish, redacted or otherwise, the report of the investigation into the incident of 25 March 2011. As we have previously stated, an ISAF investigation was conducted and concluded that the actions of the Reaper crew had been in accordance with extant procedures and Rules of Engagement. Any request to seek the publication of this document should be made directly to the NATO Supreme Headquarters Allied Powers Europe.</p> answering member constituency Rayleigh and Wickford answering member printed Mr Mark Francois question first answered 17/11/2014 16:49:30 answering member 1444 label Biography information for Mr Mark Francois
tabling member	1463 label Biography information for Lord Watson of Wyre Forest

147476

registered interest
date	10/11/2014
answering body	Ministry of Defence
answering dept id	11
answering dept short name	Defence
answering dept sort name	Defence
hansard heading	Unmanned Air Vehicles
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Defence, what his Department's policy is on basing (a) UK Reapers and (b) other remotely piloted aircraft on the Queen Elizabeth-class carriers.
tabling member constituency	West Bromwich East
tabling member printed	Mr Tom Watson
uin	214079
answer	answer is ministerial correction date of answer 18/11/2014 answer text <p>The Royal Navy has made no decision regarding the future deployment of unmanned aircraft systems (UAS) from the Queen Elizabeth Class carriers at this stage. The Royal Navy is, however, developing a Maritime UAS Strategy paper describing the requirement to 2050, and is working with industry on this issue.</p> answering member constituency Ludlow answering member printed Mr Philip Dunne question first answered 18/11/2014 17:39:41 answering member 1542 label Biography information for Philip Dunne
tabling member	1463 label Biography information for Lord Watson of Wyre Forest

143376

registered interest
date	07/11/2014
answering body	Ministry of Defence
answering dept id	11
answering dept short name	Defence
answering dept sort name	Defence
hansard heading	Unmanned Air Vehicles
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Defence, for which periods officers in the armed forces have been trained on the operation and use of drone technology in Israel and the Occupied Palestinian Territories in the last two years.
tabling member constituency	West Bromwich East
tabling member printed	Mr Tom Watson
uin	213867
answer	answer is ministerial correction date of answer 19/11/2014 answer text <p>In the last two years training on the unarmed HERMES 450 Unmanned Aircraft System has been conducted by Army personnel in Israel on a regular basis. The last training took place in July 2014. This training was a mixture of individual and pre-deployment training for HERMES operators, and technical training for support personnel. Over this period, more than 270 personnel received training by the civilian contractor in Israel. No training has been conducted within the Occupied Palestinian territories.</p> answering member constituency Rayleigh and Wickford answering member printed Mr Mark Francois question first answered 19/11/2014 17:52:21 answering member 1444 label Biography information for Mr Mark Francois
tabling member	1463 label Biography information for Lord Watson of Wyre Forest

143398

registered interest
date	07/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if he will issue a direction under Regulation 7 of the National Institue for Health and Care Excellence (NICE) (Constitution and Functions) and the Health and Social Care Information Centre (Functions) Regulations 2013 to exempt clinical commissioning groups from the requirement to comply with NICE Technology Assessment Guidance TA155, in order that NHS commissioners can make their own decision on whether to issue the drug Avastin and Lucentis.
tabling member constituency	West Bromwich East
tabling member printed	Mr Tom Watson
uin	213834
answer	answer is ministerial correction date of answer 17/11/2014 answer text <p>We have no such plans. The Government believes that drugs and treatments that are established as clinically and cost effective should be available to patients. The National Institute for Health and Care Excellence (NICE) has published technology appraisal guidance on Lucentis (ranibizumab) and Macugen (pegaptanib) for the treatment of age-related macular degeneration (TA155) that recommends Lucentis as a clinically and cost effective use of National Health Service resources for the treatment of patients with wet age-related macular degeneration meeting specific clinical criteria.</p><p> </p><p> </p><p> </p><p>Under Regulation 7, commissioners are legally required to make funding available so that clinicians can prescribe treatments recommended in NICE technology appraisal guidance to patients. This does not prevent commissioners from supporting the use of additional treatment options if they believe they would be of benefit to their local population.</p><p> </p><p> </p><p> </p><p>Avastin (bevacizumab) is not licensed for use in the treatment of wet age-related macular degeneration. Clinicians are able to prescribe drugs outside their marketing authorisation where they believe it is clinical appropriate, based on an assessment of their patient’s individual clinical circumstances.</p><p> </p><p> </p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 17/11/2014 11:14:36 answering member 4020 label Biography information for George Freeman
tabling member	1463 label Biography information for Lord Watson of Wyre Forest